Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence P Carter

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The Journal of Pharmacology and Experimental Therapeutics|March 17, 2005
Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonistsLawrence P Carter, Huifang Wu, Weibin Chen, et al.
Sleep Medicine|January 12, 2020
Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsyHelene A Emsellem, Michael J Thorpy, Gert Jan Lammers, et al.
Annals of the American Thoracic Society|May 1, 2020
Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled TrialTerri E Weaver, Christopher L Drake, Heike Benes, et al.
Human Psychopharmacology|May 28, 2022
Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoeaFrederick Vinckenbosch, Jerryll Asin, Nicolaas de Vries, et al.
Neurology and Therapy|December 9, 2022
Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model PredictionsJaime K Devine, Lindsay Schwartz, Steven Hursh, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The Journal of Pharmacology and Experimental Therapeutics|March 17, 2005
Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonistsLawrence P Carter, Huifang Wu, Weibin Chen, et al.
Sleep Medicine|January 12, 2020
Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsyHelene A Emsellem, Michael J Thorpy, Gert Jan Lammers, et al.
Annals of the American Thoracic Society|May 1, 2020
Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled TrialTerri E Weaver, Christopher L Drake, Heike Benes, et al.
Human Psychopharmacology|May 28, 2022
Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoeaFrederick Vinckenbosch, Jerryll Asin, Nicolaas de Vries, et al.
Neurology and Therapy|December 9, 2022
Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model PredictionsJaime K Devine, Lindsay Schwartz, Steven Hursh, et al.
Pageof 5